000 | 01242 a2200349 4500 | ||
---|---|---|---|
005 | 20250517223210.0 | ||
264 | 0 | _c20190408 | |
008 | 201904s 0 0 eng d | ||
022 | _a1744-8409 | ||
024 | 7 |
_a10.1080/1744666X.2018.1490178 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYoo, Dae Hyun | |
245 | 0 | 0 |
_aSwitching to biosimilars in the treatment of rheumatic diseases. _h[electronic resource] |
260 |
_bExpert review of clinical immunology _c07 2018 |
||
300 |
_a557-571 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xtherapeutic use |
650 | 0 | 4 | _aDrug Approval |
650 | 0 | 4 | _aDrug Substitution |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aExpert Testimony |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
700 | 1 | _aChoe, Jung-Yoon | |
700 | 1 | _aShim, Seung Cheol | |
700 | 1 | _aSuh, Chang-Hee | |
773 | 0 |
_tExpert review of clinical immunology _gvol. 14 _gno. 7 _gp. 557-571 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/1744666X.2018.1490178 _zAvailable from publisher's website |
999 |
_c28541702 _d28541702 |